Portal de Periódicos da CAPES

Nitric oxide mediates protein kinase C isoform translocation in rat heart during postischemic reperfusion

1999; Elsevier BV; Volume: 1453; Issue: 2 Linguagem: Inglês

10.1016/s0925-4439(98)00105-7

1879-260X

Kenichi Yoshida, Yoichi Mizukami, Masafumi Kitakaze,

Cardiac electrophysiology and arrhythmias

It is controversial whether nitric oxide (NO) is protective or deleterious against ischemia–reperfusion injury. We examined the effect of NO on PKC isoform translocation and protection against ischemia–reperfusion injury in perfused heart. An NO synthase inhibitor l-NAME (NG-nitro-l-arginine methyl ester, 3.0 μM), administered only during reperfusion but not during ischemia, inhibited the translocation of PKC-α, -δ and -ϵ isoforms to the nucleus–myofibril fraction and the translocation of PKC-α to the membrane fraction after ischemia (20 min) and reperfusion (10 min) in the perfused rat heart. NO donors, 3-morpholinosydnonimine (SIN-1) or S-nitroso-N-acetylpenicillamine (SNAP) activated purified PKC in vitro. SIN-1 also induced PKC isoform translocation in perfused heart. On the other hand, PKC selective inhibitor, calphostin C (0.2 μM) or chelerythrine (1.0 μM), aggravated the contractile dysfunction of ischemic heart during reperfusion, when they were perfused during reperfusion. These data suggest that NO generated during reperfusion following ischemia activates PKC isoforms and may protect the heart against contractile dysfunction in the perfused rat heart.